Interferon-γ: an overview of signals, mechanisms and functions
The DOI matches its Crossref record; 433 of the 443 references it cites were found in a registry or an index.
Abstract
Interferon-γ (IFN-γ) coordinates a diverse array of cellular programs through transcriptional regulation of immunologically relevant genes. This article reviews the current understanding of IFN-γ ligand, receptor, ignal transduction, and cellular effects with a focus on macrophage responses and to a lesser extent, responses from other cell types that influence macrophage function during infection. The current model for IFN-γ signal transduction is discussed, as well as signal regulation and factors conferring signal specificity. Cellular effects of IFN-γ are described, including up-regulation of pathogen recognition, antigen processing and presentation, the antiviral state, inhibition of cellular proliferation and effects on apoptosis, activation of microbicidal effector functions, immunomodulation, and leukocyte trafficking. In addition, integration of signaling and response with other cytokines and pathogen-associated molecular patterns, such as tumor necrosis factor-α, interleukin-4, type I IFNs, and lipopolysaccharide are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, the proteins encoded by these genes are all reported to be part of a signaling cascade upstream of interferon regulatory factor 1 (IRF1) and downstream of interferon-γ (IFNγ; ref. 50).”
From scPerturb: harmonized single-cell perturbation data (2024) · cites this paper as [50]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211 · cited 3×
“, peroxynitrite) to mediate cytotoxicity by a wide variety of mechanisms [281, 370, 371].”
InfluentialDarnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932 · cited 2×
“, Stat1:Stat1:IRF-9, Stat1:Stat2:IRF-9) form during signaling [102, 116–118].”
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 7×
“Chaperones such as tapasin and GP96 implicated in aiding in the efficient assembly of peptide:MHC I complexes are also up-regulated by IFN- [4, 309, 310].”
InfluentialPeroxynitrite oxidation of sulfhydryls.
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,490
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453 · cited 2×
“fend against a broad spectrum of pathogens [60, 61].”
Research works printed but not linked: 1
- Dey, 1999, Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis, J. Cell. Biochem., 72, 232, 10.1002/(sici)1097-4644(19990201)72:2<232::aid-jcb7>3.0.co;2-0 · DOI
Cited by
Items 201–300 of 1,014
Westendorf, A. M., Skibbe, K., Adamczyk, A., Buer, J., Geffers, R., Hansen, W., Pastille, E., & Jendrossek, V. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000464429 · Cited by 190
IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus
Shao, S., Tsoi, L. C., Sarkar, M. K., Xing, X., Xue, K., Uppala, R., Berthier, C. C., Zeng, C., Patrick, M., Billi, A. C., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav7561 · Cited by 185
The untold story of IFN-γ in cancer biology
Kursunel, M. A., & Esendagli, G. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.07.005 · Cited by 192
CD4 T cell differentiation in type 1 diabetes
Walker, L. S. K., & von Herrath, M. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12672 · Cited by 181
Awad, F., Assrawi, E., Jumeau, C., Georgin-Lavialle, S., Cobret, L., Duquesnoy, P., Piterboth, W., Thomas, L., Stankovic-Stojanovic, K., Louvrier, C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175336 · Cited by 191
López-Muñoz, A., Roca, F. J., Meseguer, J., & Mulero, V. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802528 · Cited by 188
“Although originally defined as an agent with direct antiviral activity, the properties of IFN- include the regulation of several aspects of the immune response, such as the stimulation of bactericidal activity of phagocytes, the stimulation of Ag presentation through class I and class II MHC molecules, the orchestrati…”
BackgroundHaldar, A. K., Saka, H. A., Piro, A. S., Dunn, J. D., Henry, S. C., Taylor, G. A., Frickel, E. M., Valdivia, R. H., & Coers, J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003414 · Cited by 185
Bonfield, T. L., Koloze, M., Lennon, D. P., Zuchowski, B., Yang, S. E., & Caplan, A. I. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00182.2009 · Cited by 188
Šestan, M., Marinović, S., Kavazović, I., Cekinović, Đ., Wueest, S., Turk Wensveen, T., Brizić, I., Jonjić, S., Konrad, D., Wensveen, F. M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.005 · Cited by 189
Baune, B. T., Smith, E., Reppermund, S., Air, T., Samaras, K., Lux, O., Brodaty, H., Sachdev, P., & Trollor, J. N. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.02.006 · Cited by 184
“, 1997), and in turn interferon gamma has repeatedly been shown to improve immunity (Schroder et al., 2004).”
BackgroundPD-L1/PD-1 Axis in Glioblastoma Multiforme
Litak, J., Mazurek, M., Grochowski, C., Kamieniak, P., & Roliński, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215347 · Cited by 180
Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus
Li, J., Li, S., Yang, L., Cao, P., & Lu, J. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1847037 · Cited by 183
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
Lensing, M., & Jabbari, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955035 · Cited by 178
Inflammation‐related cytokines in oral lichen planus: an overview
Lu, R., Zhang, J., Sun, W., Du, G., & Zhou, G. (2015) · Journal of Oral Pathology & Medicine · doi:10.1111/jop.12142 · Cited by 184
Mejías, R., Pérez-Yagüe, S., Gutiérrez, L., Cabrera, L. I., Spada, R., Acedo, P., Serna, C. J., Lázaro, F. J., Villanueva, Á., Morales, M. D. P., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.008 · Cited by 186
Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention
Wu, D., & Meydani, S. N. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108023 · Cited by 187
How interferon-γ keeps autoimmune diseases in check
Kelchtermans, H., Billiau, A., & Matthys, P. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.002 · Cited by 184
“An overview of these anti-inflammatory and proinflammatory properties of IFN-g is shown in Figure 2 (for the proinflammatory features of IFN-g, the reader is referred to extensive reviews [ 39 ,40]).”
BackgroundIFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment
Nirschl, C. J., Suárez-Fariñas, M., Izar, B., Prakadan, S., Dannenfelser, R., Tirosh, I., Liu, Y., Zhu, Q., Devi, K. S. P., Carroll, S. L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.016 · Cited by 182
McElwee, K. J., Gilhar, A., Tobin, D. J., Ramot, Y., Sundberg, J. P., Nakamura, M., Bertolini, M., Inui, S., Tokura, Y., King, L. E., et al. (2013) · Experimental Dermatology · doi:10.1111/exd.12209 · Cited by 178
Villegas-Mendez, A., Greig, R., Shaw, T. N., de Souza, J. B., Gwyer Findlay, E., Stumhofer, J. S., Hafalla, J. C. R., Blount, D. G., Hunter, C. A., Riley, E. M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200688 · Cited by 177
Ferretti, M. T., Merlini, M., Späni, C., Gericke, C., Schweizer, N., Enzmann, G., Engelhardt, B., Kulic, L., Suter, T., & Nitsch, R. M. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.02.009 · Cited by 177
IL-28A, IL-28B, and IL-29: Promising cytokines with type I interferon-like properties
Witte, K., Witte, E., Sabat, R., & Wolk, K. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.04.002 · Cited by 169
“They exert direct anti-viral and cytostatic as well as immunomodulatory effects [33,34].”
BackgroundHoyer, F. F., Naxerova, K., Schloss, M. J., Hulsmans, M., Nair, A. V., Dutta, P., Calcagno, D. M., Herisson, F., Anzai, A., Sun, Y., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.010 · Cited by 175
“This intrigued us since interferon-ɣ (IFNɣ) is a prototypical macrophage activator (Schroder et al., 2004).”
BackgroundThe expression of CD8α discriminates distinct T cell subsets in teleost fish
Takizawa, F., Dijkstra, J. M., Kotterba, P., Korytář, T., Kock, H., Köllner, B., Jaureguiberry, B., Nakanishi, T., & Fischer, U. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.02.008 · Cited by 176
“In humans and mice, FN- plays important roles in the regulation of adaptive immunity nd cellular cytotoxicity (Schroder et al., 2004).”
BackgroundInterleukin 10 (IL-10)-mediated Immunosuppression
Mittal, S. K., Cho, K.-J., Ishido, S., & Roche, P. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.682708 · Cited by 166
“IFN- treatment of M promotes expression of the class II transactivator CIITA that converts the cells from MHC-II-negative M to MHC-II-expressing APCs (4) and enhances expression of CD86 and CD40, key co-stimulatory molecules required for efficient APC function (16, 28, 29).”
BackgroundEngholm-Keller, K., Birck, P., Størling, J., Pociot, F., Mandrup-Poulsen, T., & Larsen, M. R. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.08.007 · Cited by 176
Page, S. T., Plymate, S. R., Bremner, W. J., Matsumoto, A. M., Hess, D. L., Lin, D. W., Amory, J. K., Nelson, P. S., & Wu, J. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00484.2005 · Cited by 170
Hudspeth, K., Silva-Santos, B., & Mavilio, D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00069 · Cited by 163
“It is well known that the production of these pro-inflammatory cytokines is essential for the clearance of bacterial and viral pathogens as well as in the modulation of immune responses (Pfeffer, 2003; Schroder et al., 2004).”
BackgroundTeo, P. Y., Yang, C., Whilding, L. M., Parente‐Pereira, A. C., Maher, J., George, A. J. T., Hedrick, J. L., Yang, Y. Y., & Ghaem‐Maghami, S. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500089 · Cited by 172
Monsalve, E., Pérez, M. A., Rubio, A., Ruiz-Hidalgo, M. J., Baladrón, V., García-Ramírez, J. J., Gómez, J. C., Laborda, J., & Díaz-Guerra, M. J. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5362 · Cited by 174
“Although biochemical and genetic studies show that STAT1 plays a critical role in IFN- -dependent signaling (5), recent work reveals that additional signals are required for the full range of responses caused by IFN- (6, 7).”
BackgroundMethodInfluentialDynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium tuberculosis
Desvignes, L., Wolf, A. J., & Ernst, J. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200255 · Cited by 173
Advances in Understanding the Immunological Pathways in Psoriasis
Georgescu, S. R., Tampa, M. Ş., Căruntu, C., Sârbu, M. I., Mitran, C. I., Mitran, M.-I., Matei, C., Constantin, C., & Neagu, M. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030739 · Cited by 186
“The production of this cytokine is mostly controlled by IL-12 and IL-18 and macrophages, dendritic cells and naive T cells are the main responsive cells [1,49].”
BackgroundZhang, M., Huang, L., Ding, G., Huang, H., Cao, G., Sun, X., Lou, N., Wei, Q., Shen, T., Xu, X., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000308 · Cited by 172
Molecular and Cellular Mechanisms of Action of Cannabidiol
Naya, N. M., Kelly, J., Corna, G., Golino, M., Abbate, A., & Toldo, S. A. (2023) · Molecules · doi:10.3390/molecules28165980 · Cited by 192
Cellular immunity in ASFV responses
Takamatsu, H.-H., Denyer, M. S., Lacasta, A., Stirling, C. M. A., Argilaguet, J. M., Netherton, C. L., Oura, C. A. L., Martins, C., & Rodríguez, F. (2013) · Virus Research · doi:10.1016/j.virusres.2012.11.009 · Cited by 171
Metabolic Regulation of Natural Killer Cell IFN-γ Production
Mah, A. Y., & Cooper, M. A. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016017387 · Cited by 161
Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
Li, C., Zhang, N., Zhou, J., Ding, C., Jin, Y., Cui, X., Pu, K., & Zhu, Y. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0035 · Cited by 161
Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet
Lussier, D. M., Woolf, E. C., Johnson, J. L., Brooks, K. S., Blattman, J. N., & Scheck, A. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2337-7 · Cited by 163
“Shifting the balance toward a Th1 immune response leads to a general change in cytokine milieu at the tumor site which alters antigen presenting cell maturation and amount of overall immune cell activation [36–41].”
BackgroundDing, H., Wang, G., Yu, Z., Sun, H., & Wang, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113683 · Cited by 159
Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection.
Wu, S., & Sun, J. (2011) · PubMed · Cited by 208
Macrophage activation syndrome and cytokine-directed therapies
Schulert, G. S., & Grom, A. A. (2014) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2014.03.002 · Cited by 163
Price, J. V., & Vance, R. E. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.015 · Cited by 165
“Robust stimulation by IFN-g almost invariably renders a macrophage completely inhospitable to invading microbes due to the combination of antimicrobial responses induced by this cytokine (Schroder et al., 2004).”
BackgroundVremec, D., O'Keeffe, M., Hochrein, H., Fuchsberger, M., Caminschi, I., Lahoud, M., & Shortman, K. (2007) · Blood · doi:10.1182/blood-2006-05-015354 · Cited by 155
Complement and Toll-like receptors: Key regulators of adaptive immune responses
Hawlisch, H., & Köhl, J. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.028 · Cited by 168
Dual-specificity phosphatase 1: a critical regulator of innate immune responses
Abraham, S. M., & Clark, A. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341018 · Cited by 169
Schroeder, M., Schaumburg, B., Mueller, Z., Parplys, A., Jarczak, D., Roedl, K., Nierhaus, A., de Heer, G., Grensemann, J., Schneider, B., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1969869 · Cited by 161
No Love Lost Between Viruses and Interferons
Fensterl, V., Chattopadhyay, S., & Sen, G. C. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055249 · Cited by 182
“In consequence, the STAT1 homodimer, GAF, is the dominant transcription factor activated by type II IFNs and activates the transcription of genes containing a gamma-activated site (GAS) in their promoters (73).”
Lu, R., Munroe, M. E., Guthridge, J. M., Bean, K. M., Fife, D. A., Chen, H., Slight-Webb, S. R., Keith, M. P., Harley, J. B., & James, J. A. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.001 · Cited by 164
Interferon-Gamma-Mediated Osteoimmunology
Tang, M., Tian, L., Luo, G., & Yu, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01508 · Cited by 159
Bacterial Ligands Generated in a Phagosome Are Targets of the Cytosolic Innate Immune System
Herskovits, A. A., Auerbuch, V., & Portnoy, D. A. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030051 · Cited by 162
“acidic hydrolytic compartments [2].”
Susceptibility to nontuberculous mycobacterial lung disease: Table 1—
Sexton, P., & Harrison, A. C. (2008) · European Respiratory Journal · doi:10.1183/09031936.00140007 · Cited by 160
ETS transcription factors and regulation of immunity
Gallant, S., & Gilkeson, G. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0017-z · Cited by 163
Chegou, N. N., Heyckendorf, J., Walzl, G., Lange, C., & Ruhwald, M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00151413 · Cited by 163
Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection
Brown, A. F., Murphy, A. G., Lalor, S. J., Leech, J. M., O’Keeffe, K. M., Mac Aogáin, M., O’Halloran, D. P., Lacey, K. A., Tavakol, M., Hearnden, C. H., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005226 · Cited by 166
“T cells do not directly kill bacteria but, via cytokines such as IFNγ and IL-17, they can orchestrate many downstream effects on phagocytes that enhance their microbicidal activity [23,24].”
BackgroundNoncytotoxic Functions of NK Cells: Direct Pathogen Restriction and Assistance to Adaptive Immunity
Strowig, T., Brilot, F., & Münz, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7785 · Cited by 176
“Because these functions have been more comprehensively summarized elsewhere (61, 62), we will focus on the role of IFN7787 The Journal of Immunology”
BackgroundDirect Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 178
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
García-Díaz, Á., Shin, D. S., Moreno, B. H., Saco, J. D., Escuin-Ordinas, H., Rodriguez, G. A., Zaretsky, J. M., Sun, L., Hugo, W., Wang, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.113 · Cited by 162
McCall, M. B. B., & Sauerwein, R. W. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310137 · Cited by 196
“[1]).”
Spaceflight effects on T lymphocyte distribution, function and gene expression
Gridley, D. S., Slater, J. M., Luo-Owen, X., Rizvi, A., Chapes, S. K., Stodieck, L. S., Ferguson, V. L., & Pecaut, M. J. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91126.2008 · Cited by 151
Achar, A., & Ghosh, C. (2020) · Cells · doi:10.3390/cells9112360 · Cited by 159
Immunogenic ferroptosis and where to find it?
Demuynck, R., Efimova, I., Naessens, F., & Krysko, D. V. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003430 · Cited by 168
Autophagy and adaptive immunity
Crotzer, V. L., & Blum, J. S. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03321.x · Cited by 146
Fungal Engagement of the C-Type Lectin Mincle Suppresses Dectin-1-Induced Antifungal Immunity
Wevers, B. A., Kaptein, T. M., Willems, E., Theelen, B., Boekhout, T., Geijtenbeek, T. B. H., & Gringhuis, S. I. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.03.008 · Cited by 168
“TH1-pro- 494 Cell Host & Microbe 15, 494–505, April 9, 2014 ª2014 Elsevier In duced IFN-g is essential for optimal activation of phagocytic effector cell functions (e.g., release of nitric oxide and production of reactive oxygen intermediates) to combat fungal persistence (Schroder et al., 2004).”
The Life and Death of Epithelia During Inflammation: Lessons Learned from the Gut
Koch, S., & Nusrat, A. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120905 · Cited by 154
Abrams, M. E., Johnson, K. A., Perelman, S. S., Zhang, L.-S., Endapally, S., Mar, K. B., Thompson, B. M., McDonald, J. G., Schoggins, J. W., Radhakrishnan, A., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0701-5 · Cited by 153
Herová, M., Schmid, M., Gemperle, C., & Hersberger, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402166 · Cited by 157
Caescu, C. I., Guo, X., Tesfa, L., Bhagat, T. D., Verma, A. K., Zheng, D., & Stanley, E. R. (2015) · Blood · doi:10.1182/blood-2014-10-608000 · Cited by 167
The immunological balance between host and parasite in malaria
Deroost, K., Pham, T., Opdenakker, G., & den Steen, P. E. V. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv046 · Cited by 182
Checker, R., Sharma, D., Sandur, S. K., Khanam, S., & Poduval, T. B. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.03.022 · Cited by 156
The proinflammatory cytokine-induced IRG1 protein associates with mitochondria
Degrandi, D., Hoffmann, R., Beuter-Gunia, C., & Pfeffer, K. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0013 · Cited by 155
Interferons limit inflammatory responses by induction of tristetraprolin
Sauer, I. (2006) · Blood · doi:10.1182/blood-2005-07-3058 · Cited by 151
Ras-Mediated Deregulation of the Circadian Clock in Cancer
Relógio, A., Thomas, P., Medina-Pérez, P., Reischl, S., Bervoets, S., Gloc, E., Riemer, P., Mang-Fatehi, S., Maier, B., Schäfer, R., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004338 · Cited by 147
“Discriminative genes associated with cancer pathways (Table 2) include IFNGR2 (involved in the Jak-STAT pathway) [53], PITX2 (TGF-b pathway), RFWD2 (p53 signalling), PPARc (Wnt pathway).”
BackgroundCytokines as therapeutic targets in SLE
Rönnblom, L., & Elkon, K. B. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.64 · Cited by 168
“Through these activities, IFN-γ activates macrophages, NK cells and cytotoxic T cells, but can also modulate the function of helper T cells and regulatory T cells”
BackgroundSchmeel, L. C., Schmeel, F. C., Coch, C., & Schmidt‐Wolf, I. G. H. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1864-3 · Cited by 159
“Enhanced expression of the major histocompatibility complex (MHC) I molecule and improved cytotoxicity reflect two more IFN-γ properties (Schroder et al. 2004).”
BackgroundPharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
Choi, J., Cooper, M. L., Alahmari, B., Ritchey, J., Collins, L. I., Holt, M. S., & DiPersio, J. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109799 · Cited by 158
“Alternatively, JAK1/JAK2 inhibitors perhaps reduce IFNcR signaling in recipients or donor BM-derived antigen presenting cells (APCs), which may also contribute to reduction of MHC I and II expression in recipient APCs [11,12].”
BackgroundIFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
Thiem, A., Hesbacher, S., Kneitz, H., di Primio, T., Heppt, M. V., Hermanns, H. M., Goebeler, M., Meierjohann, S., Houben, R., & Schrama, D. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1403-9 · Cited by 153
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Stephens, A. J., Burgess-Brown, N. A., & Jiang, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696791 · Cited by 153
Pillarisetty, V. G., Katz, S. C., Bleier, J. I., Shah, A. B., & DeMatteo, R. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2612 · Cited by 144
“IFNplays a critical role in bridging innate and adaptive immunity by increasing Ag presentation through the MHC class I and II pathways (3, 4).”
BackgroundLi, Q., Harden, J. L., Anderson, C. D., & Egilmez, N. K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502615 · Cited by 144
“Moreover, IFN-g–mediated intracellular signaling events are similarly brief due to its short halflife and the rapid upregulation of suppressor of cytokine signaling-1, which blocks signaling from the IFN-g receptor (10).”
BackgroundHuman T Cell Leukemia Virus Type 1: Persistence and Pathogenesis
Bangham, C. R. M. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053222 · Cited by 170
JAK inhibitors and infections risk: focus on herpes zoster
Sunzini, F., McInnes, I., & Siebert, S. (2020) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20936059 · Cited by 157
Zheng, T., Kang, M., Crothers, K. A., Zhu, Z., Liu, W. Q., Lee, C. G., Rabach, L. A., Chapman, H. A., Homer, R., Aldous, D., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8106 · Cited by 151
“It is now appreciated to be the prototypic Th1/Tc1 cytokine and is known to play a key role in the regulation of diverse immune responses, including pathogen recognition, Ag processing and presentation, cellular proliferation, microbicidal effector activation, and leukocyte trafficking (1).”
BackgroundOsteoblasts secrete Cxcl9 to regulate angiogenesis in bone
Huang, B., Wang, W., Li, Q., Wang, Z., Yan, B., Zhang, Z., Wang, L., Huang, M., Jia, C., Lu, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13885 · Cited by 152
Boulch, M., Cazaux, M., Cuffel, A., Guérin, M. V., Garcia, Z., Alonso, R., Lemaître, F., Beer, A., Corre, B., Menger, L., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00570-7 · Cited by 163
Probiotics in the Management of Lung Diseases
Mortaz, E., Adcock, I. M., Folkerts, G., Barnes, P. J., Vos, A. P., & Garssen, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/751068 · Cited by 156
Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-γ
Hoekstra, M. E., Bornes, L., Dijkgraaf, F. E., Philips, D., Pardieck, I. N., Toebes, M., Thommen, D. S., van Rheenen, J., & Schumacher, T. N. (2020) · Nature Cancer · doi:10.1038/s43018-020-0036-4 · Cited by 161
STAT1 and pathogens, not a friendly relationship
Najjar, I., & Fagard, R. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.009 · Cited by 145
“In macrophages, the IFNg/ STAT1 pathway activates microbicidal activity through the induction of NADPH oxidase and iNOS, which are key components of the efficient killing of bacteria, viruses, parasites and fungi (see: [199] ).”
BackgroundWatters, C., Fleming, D. F., Bishop, D. K., & Rumbaugh, K. P. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.05.007 · Cited by 160
Nan, Y., Wu, C., & Zhang, Y.-J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01758 · Cited by 146
Functionally heterogeneous human satellite cells identified by single cell RNA sequencing
Barruet, E., Garcia, S. M., Striedinger, K., Wu, J., Lee, S., Byrnes, L. E., Wong, A., Sun, X., Tamaki, S. J., Brack, A. S., et al. (2020) · eLife · doi:10.7554/elife.51576 · Cited by 151
“…femoris sample (i.e. clusters expressing genes associated with NOTCH signaling (0), cellular stress (1), response to IFN gamma (cluster 2-CCL2, MYC, ICAM1, IRF1) (Schroder et al., 2004), ECM and cell adhesion (cluster 3-CAV1, COLs, VCAM1) (Figure 1—figure supplement 2d and Supplementary file 2).”
BackgroundDivergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients
Oja, A. E., Saris, A., Ghandour, C. A., Kragten, N. A. M., Hogema, B. M., Nossent, E. J., Heunks, L. M. A., Cuvalay, S., Slot, E., Linty, F., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048908 · Cited by 133
Oral pathogenesis of Aggregatibacter actinomycetemcomitans
Gholizadeh, P., Pormohammad, A., Eslami, H., Shokouhi, B., Fakhrzadeh, V., & Kafil, H. S. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.11.001 · Cited by 144
Th1/Th2/Th17/Treg cytokines in Guillain–Barré syndrome and experimental autoimmune neuritis
Zhang, H., Zheng, X., & Zhu, J. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.005 · Cited by 146
“In addition, IFN-g induces B cell class switching, apoptosis of T cell, and enhancement of production of other proinflammatory cytokines such as TNF-a, IL-1b, and IL-6 [70].”
BackgroundDifferential Regulation of TLR-Dependent MyD88 and TRIF Signaling Pathways by Free Zinc Ions
Brieger, A., Rink, L., & Haase, H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301261 · Cited by 139
Early NK Cell-Derived IFN-γ Is Essential to Host Defense in Neutropenic Invasive Aspergillosis
Park, S. J., Hughes, M. A., Burdick, M., Strieter, R. M., & Mehrad, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803462 · Cited by 137
“development of Th-1-acquired immunity (65).”
Goodman, S. B., Gibon, E., Pajarinen, J., Lin, T., Keeney, M., Ren, P., Nich, C., Yao, Z., Egashira, K., Yang, F., et al. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0962 · Cited by 152
Zhang, T., Wu, M.-R., & Sentman, C. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103495 · Cited by 139
Won, E. J., Ju, J. K., Cho, Y., Jin, H., Park, K., Kim, T., Kwon, Y. S., Kee, H. J., Kim, J.-C., Kee, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11187 · Cited by 155
Qiu, X., Fernando, L., Alimonti, J. B., Melito, P. L., Feldmann, F., Dick, D., Ströher, U., Feldmann, H., & Jones, S. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005547 · Cited by 147
“IFN-c has immunoregulatory activities during an immune response to viral pathogens, and in addition it has antiviral effects that may inhibit early viral replication and thereby slow the infection [39].”
BackgroundmTOR-Mediated Regulation of Dendritic Cell Differentiation and Function
Sukhbaatar, N., Hengstschläger, M., & Weichhart, T. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.009 · Cited by 128
Metadata
- Authors
- Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A.
- Affiliations
- The University of Queensland (AU)
- Monash Medical Centre (AU)
- Corresponding author
- Hume, David A
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-02
- Volume
- 75
- Issue
- 2
- Pages
- 163-189
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2167017590
- Cited by
- 4,120
- References
- 443
- Citations by year
- 2026: 141 · 2025: 166 · 2024: 208 · 2023: 231 · 2022: 229 · 2021: 252 · 2020: 243 · 2019: 213 · 2018: 193 · 2017: 225 · 2016: 236 · 2015: 246 · 2014: 209 · 2013: 224 · 2012: 195
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon-gamma, IFN-gamma receptor, signal transduction, macrophage response, transcriptional regulation, antigen processing and presentation, antiviral state, apoptosis, immunomodulation, leukocyte migration, cytokine signaling, pathogen-associated molecular patterns
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Inflammation, Interferon-gamma, Macrophages, Signal Transduction, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.